The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome
Conclusion
Nesfatin-1 which is known to play a role in the pathophysiology of insulin resistance can be a beneficial target in developing new therapeutic targets for treatment of patients with obesity without any toxic effects in the future.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Brain | Eating Disorders & Weight Management | Endocrinology | Insulin | Laboratory Medicine | Men | Metabolic Syndrome | Neurology | Obesity | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study | Toxicology